TGFB1 and diabetic kidney disease: Cell study by Tang et al. showed that MaR1 inhibited NLRP3 inflammatory body and TGF-β1 and fibronectin in glomerular mesangial cells, thus speculating that MaR1 may protect DKD by reducing inflammation and early fibrosis [33].